Tell the Trump Administration to Prioritize Obesity Care

Background: Under current law, Medicare’s prescription drug benefit (Part D) excludes “agents when used for anorexia, weight loss, or weight gain”. This exclusion has prevented Medicare from covering obesity medications and has allowed Medicaid plans to opt out of providing such coverage.

Last year, the Centers for Medicare and Medicaid Services (CMS) released a Proposed Rule to expand coverage for obesity medications under Medicare and Medicaid. Thousands of advocates voiced their support for the expanded coverage during the Public Comment period. However, the Trump Administration made the decision not to finalize the expanded coverage, and stated there was possible future regulatory action.

Take Action Now: Use OAC’s advocacy tool to send a letter to the Trump Administration asking them to prioritize obesity care by supporting CMS in expanding coverage for obesity medications.

It’s Easy to Advocate! Use our easy automated message generator below to get started. We encourage you to personalize this letter before sending by including your story and thoughts before sending.